1684
N. Armoush, P. Kataria, and D. P. Becker
(10/90) to afford the desired sulfonamide-cyclobutanone 3c (140 mg, 90%) as
a white crystalline solid: mp 173–176 8C. Rf ¼ 0.3 (EA–toluene, 10:90). FT-
IR (KBr) 3582, 3054, 1791, 1421, 896 cm21; 1H NMR (300 MHz, CDCl3) d
7.77 (2H, d, J ¼ 8.2 Hz), 7.32 (2H, d, J ¼ 8.1 Hz), 5.04 (1H, d, J ¼ 7.9 Hz),
4.69 (1H, q, J ¼ 8.6 Hz), 3.00–2.71 (2H, m), 2.44 (3H, t, J ¼ 5.1 Hz), 2.37
(1H, m), 1.81 (1H, m). 13C NMR (75 MHz, CDCl3) d 207.8, 137.6, 133.9,
129.2, 118.3, 62.9, 46.1, 35.8, 29.8. MS m/z (% rel. int.) 238.47 (25,
M 2 1), 219.27 (100, M-benzyl). HRMS calcd. for C11H13NO3S (MHþ):
240.0694; found: 240.0694.
N,4-Dimethyl-N-(2-oxocyclobutyl)benzenesulfonamide (3d)
1,2-Bis(trimethylsilyloxy)cyclobutene (160 mg, 0.60 mmol) was added to a
solution of N-methyl-p-toluene sulfonamide (144 mg, 0.78 mmol) in 1.0 M
HCl/ether (3 ml) at 0 8C. The reaction mixture was heated at 55 8C for
3.5 h, and then the solvent was removed under vacuum. Chromatography
on silica gel eluting with 1/99 ethyl acetate/dichloromethane provided
N,4-dimethyl-N-(2-oxocyclobutyl)benzenesulfonamide 3d as an oil (123 mg,
80%). Rf ¼ 0.4 (EtOAc–DCM, 10:90). IR (thin film) 1790, 1661, 1513,
1
908, 731 cm21; H NMR (300 MHz, CDCl3) d 7.71 (2H, d, J ¼ 8.24 Hz),
7.30 (2H, d, J ¼ 7.96 Hz), 5.34 (1H, t, J ¼ 8.7, 10.7 Hz), 2.88–2.78 (2H,
m), 2.70 (3H, s), 2.64 (3H, s), 2.23 (1H, dd, J ¼ 4.6, 10.7 Hz), 1.97 (1H,
m); 13C NMR (75 MHz, CDCl3) d 204.0, 144.1, 135.9, 130.0, 127.3, 71.4,
41.9, 31.0, 22.1, 16.2; MS m/z ¼ 91 (tropylium ion), m/z ¼ 155
(Mþ 2 98, loss of Me-N-cyclobutanone), m/z ¼ 225 (Mþ 2 28, loss of
CO), m/z ¼ 211 (Mþ 2 42, loss of ketene), m/z ¼ 254 (MHþ). HRMS
calcd. for C12H15NO3SNa (M þ Naþ): 276.0670; found: 276.0676.
N-(2-Oxocyclobutyl)-2-phenylacetamide (3e)
1,2-Bis(trimethylsilyloxy)cyclobutene (255 mg, 1.11 mmol) was added to a
solution of phenylacetamide (150 mg, 1.11 mmol) in 1.0 M HCl/ether
(3 ml) and dichloromethane (2 ml) at 0 8C. The reaction mixture was
heated at 55 8C for 3.5 h, and then the solvent was removed under
vacuum. Chromatography on silica gel eluting with 30/70 ethyl acetate/
dichloromethane provided N-(2-oxocyclobutyl)-2-phenylacetamide 3e as
an oil (88 mg, 39%). Rf ¼ 0.3 (EtOAc–DCM, 10:90). IR (thin film) 3274,
1790, 1647, 907, 731 cm21 1H NMR (300 MHz, CDCl3) d 7.23–7.37
;
(5H, m), 5.38 (1H, s), 5.19 (2H, s), 4.78–4.87 (1H, q, J ¼ 7.91, 8.05 Hz),
2.86 (2H, m), 2.29–2.41 (1H, m), 1.95–2.08 (1H, m); 13C NMR (75 MHz,
CDCl3) d 205.9, 171.3, 134.5, 129.6, 127.7, 64.4, 43.3, 42.2, 19.6; MS:
m/z ¼ 91.1 (tropylium ion), m/z ¼ 119 (Mþ 2 84, loss of N-H cyclobuta-
none), m/z ¼ 161 (Mþ 2 42, loss of ketene), m/z ¼ 175 (Mþ 2 28, loss